Centiva Capital’s Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 CRHC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-26,667
Closed -$48K 1501
2020
Q4
$48K Buy
+26,667
New +$32.8K ﹤0.01% 866

Other funds holding CRHC.WS

Centiva Capital's CRHC.WS Position: Q1 2021 in Review

Centiva Capital sold out of Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (CRHC.WS) in Q1 2021, closing a stake of 26,667 shares — an estimated $48K sold.

Centiva Capital first reported a position in CRHC.WS in Q4 2020 and held it in 1 quarter. The position peaked at $48K in Q4 2020. 53 funds tracked by Wall St. Rank hold CRHC.WS as of Q1 2021.

  • Centiva Capital reported no remaining Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2021 after selling out during the quarter.
  • Centiva Capital sold 26,667 Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2021, an estimated $48K.
  • Centiva Capital first reported a position in Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2020 and held it in 1 quarter.
  • Centiva Capital's Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $48K in Q4 2020.
  • 53 funds tracked by Wall St. Rank held Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2021.

Based on Centiva Capital's 13F filing for Q1 2021, filed 17 May 2021.